Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03927482 · ClinicalTrials.gov registry record · NA
CARES: A Mobile Health Program for Alcohol Risk Reduction
A NA study of Alcohol Abuse, sponsored by The Miriam Hospital.
- Completed
- Registry status
- NA
- Development phase
- 239
- Enrollment target
- 1
- Study location
NCT03927482: Completed NA study of Alcohol Abuse, sponsored by The Miriam Hospital.
NCT03927482 is a NA study of Alcohol Abuse that has completed, run by The Miriam Hospital. The registered enrollment target is 239 participants, below the 708-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03927482, a NA study of Alcohol Abuse, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 239 participants
- Enrollment target
- 1
- Study location
Study Summary
In this fast-track STTR, Phase 1 will develop and test a mobile phone app among 40 adult community college students. The app is designed to reduce risky drinking behaviors and improve user safety. In Phase 2 the app ("CARES") will be tested with 200 adult community college students who drink alcohol. Participants will be randomly assigned to the "CARES" app or an alcohol education control condition and will use the app for 12 weeks. Six month outcomes will assess changes in drinking related behaviors.
Primary Outcome
Average drinks based on 30 day timeline follow back of all alcohol consumption
Conditions Studied
Interventions
- BEHAVIORAL CARES mobile smart phone app
- BEHAVIORAL Check Your Drinking
Study Locations (1)
Rhode Island
- The Miriam Hospital- CORO building - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2018-08-02 |
| Est. Completion | 2022-01-31 |
| Phase | NA |
What the finished NCT03927482 record still lists
NCT03927482 is an interventional study that assigns participants to a tested intervention. The registered 239 participants enrollment target is mid-sized for trials with a published cap, below the 708-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Alcohol Abuse appearing as the primary indexed condition, and to 2 interventions - of which CARES mobile smart phone app is the first listed.
NCT03927482 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT03927482 about?
NCT03927482 is a clinical study titled "CARES: A Mobile Health Program for Alcohol Risk Reduction". In this fast-track STTR, Phase 1 will develop and test a mobile phone app among 40 adult community college students. The app is designed to reduce risky drinking behaviors and improve user safety. In Phase 2 the app ("CARES") will be tested with 200 adult community college students who drink alcohol...
What is the current status of trial NCT03927482?
This trial is currently completed. It is a NA study. The enrollment target is 239 participants. The study started on 2018-08-02. Estimated completion is 2022-01-31.
What conditions does trial NCT03927482 study?
This clinical trial studies the following conditions: Alcohol Abuse.
What interventions are being tested in trial NCT03927482?
The interventions under investigation include: CARES mobile smart phone app (BEHAVIORAL), Check Your Drinking (BEHAVIORAL).
Who is sponsoring clinical trial NCT03927482?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03927482 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03927482's enrollment target sits among peer trials
239 19th of 46 higher than 28 of 46 other Alcohol Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety
RECRUITING · NA
-
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
RECRUITING · NA
-
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
RECRUITING · NA
-
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI